Grassley whistleblower letter
This article was originally published in The Tan Sheet
Executive Summary
Sen. Chuck Grassley (R-Iowa) asks FDA to "address allegations that administrative action may be taken against" agency whistleblower David Graham, MD, "including that he may be terminated or transferred against his wishes to a job other than conducting scientific research," in a Nov. 29 letter to Acting Commissioner Lester Crawford, PhD. Graham, associate director for science at FDA's Office of Drug Safety, testified at a Nov. 18 Senate Finance Committee hearing on Vioxx (1"The Tan Sheet" Nov. 22, 2004, p. 15)...